Treatment–Refractory Schizophrenia

Treatment–Refractory Schizophrenia
Author: Peter F. Buckley
Publisher: Springer Science & Business Media
Total Pages: 231
Release: 2014-03-18
Genre: Medical
ISBN: 3642452574

Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care. In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.

First Episode Psychosis

First Episode Psychosis
Author: Katherine J. Aitchison
Publisher: CRC Press
Total Pages: 152
Release: 1999-02-17
Genre: Medical
ISBN: 9781853174353

The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management.

The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia

The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia
Author: American Psychiatric Association
Publisher: American Psychiatric Pub
Total Pages: 220
Release: 2016
Genre: Medical
ISBN: 0890426775

The guideline offers clear, concise, and actionable recommendation statements to help clinicians to incorporate recommendations into clinical practice, with the goal of improving quality of care. Each recommendation is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms.

Polypharmacy in Psychiatry

Polypharmacy in Psychiatry
Author: S. Nassir Ghaemi
Publisher: CRC Press
Total Pages: 363
Release: 2002-05-06
Genre: Medical
ISBN: 020390902X

This practical reference examines the advantages and disadvantages of polypharmacy in psychiatry, and provides up-to-date clinical guidelines on the appropriate use of combinations of pharmacological therapy in major psychiatric disorders-including multidisciplinary approaches to treatment, such as social work and psychopharmacology, and an examina

Deprescribing in Psychiatry

Deprescribing in Psychiatry
Author: Swapnil Gupta
Publisher: Oxford University Press, USA
Total Pages: 265
Release: 2019
Genre: Medical
ISBN: 0190654813

Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. This book describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It outlines the how and when, and gives recommendations on what the prescriber and patient may encounter along the way.

Drug Induced Movement Disorders

Drug Induced Movement Disorders
Author: Stewart Factor
Publisher: John Wiley & Sons
Total Pages: 480
Release: 2008-04-15
Genre: Medical
ISBN: 140513755X

The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.

Dyskinesia

Dyskinesia
Author: D.E. Casey
Publisher: Springer Science & Business Media
Total Pages: 368
Release: 2013-03-12
Genre: Medical
ISBN: 364270140X

Papers Presented at an International Symposium, Held in 1984 at Kollekolle, Denmark

The Psychopharmacology of Schizophrenia

The Psychopharmacology of Schizophrenia
Author: Michael A. Reveley
Publisher: CRC Press
Total Pages: 288
Release: 2000-01-01
Genre: Medical
ISBN: 9780340759127

This unique and timely book examines the basic and clinical sciences relevant to schizophrenia and relates them to current treatment strategies. Through describing current thinking on the aetiology and pathophysiology of schizophrenia as relevant to the psychopharmacology of the disorder, the reader gains a fuller understanding of the rationale for psychopharmacological approaches to treatment. Neuroimaging and neuropsychology are covered in detail as well as further chapters on clinical strategies for treatment of schizophrenia with both conventional and atypical antipsychotic treatments. Practical advice on the management of schizophrenia in the community is also given. Bringing together new developments and advances in the field, while discussing important issues relevant to the long-term treatment necessary for this disorder, the result is an essential book for psychiatrists and psychopharmacologists at all levels.

Antipsychotic Long-acting Injections

Antipsychotic Long-acting Injections
Author: Peter Haddad
Publisher: Oxford University Press
Total Pages: 266
Release: 2016-05-10
Genre: Medical
ISBN: 0191045780

Antipsychotic Long-acting Injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Since the initial publication of Antipsychotic Long-acting Injections in 2010, new trial data have been published on long-acting injection (LAI) preparations of the drugs Risperidone, Paliperidone, and Olanzapine. Furthermore, a new LAI preparation of the drug Aripiprazole has recently been approved for clinical use in the United States and is likely to be approved in Europe soon. The second edition of this successful book has been fully updated to include this new data, with reference to both observational studies and randomized controlled trials, as well as other new developments in the clinical use of antipsychotic LAIs. New chapters have been added covering the comparison between oral and injectable antipsychotics, Olanzapine LAI, Aripiprazole LAI, and the practicalities of organizing a specialized clinic for long-acting injectable antipsychotics. Existing chapters have also been thoroughly updated to take into account the most recently published research. Antipsychotic Long-acting Injections, Second edition brings together clinical and research findings on LAIs in a comprehensive volume, with chapters written by international experts.